In this issue:
Wells score for DVT risk stratification in inpatients
CTPA and PE after primary joint arthroplasty
6-month vs. extended oral anticoagulation after a first PE
Anticoagulation ±retrievable IVC filter and recurrent PE risk
IVC filter retrieval in NZ
Occult cancer screening in unprovoked VTE
Perioperative bridging anticoagulation in AF
Risks with warfarin interruption for invasive procedures
Idarucizumab for dabigatran reversal
Ambrisentan + tadalafil in PAH
Riociguat in borderline/manifest COPD-associated PH
Bosentan for sarcoidosis-associated PH
Please login below to download this issue (PDF)